#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukocyte adhesion deficiency type I Renal disorder Immunodeficiency PIK3CA related overgrowth spectrum Nephroblastoma Leukodystrophy Lung adenocarcinoma Spinal cord injury cervical Epstein-Barr virus associated lymphoproliferative disorder Oesophageal atresia Hodgkin's disease recurrent Chronic hepatitis B Thyroid cancer metastatic Post transplant lymphoproliferative disorder Glomerulonephritis rapidly progressive More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Trials in Disease Myelodysplastic syndrome – Basic Information Biotinidase deficiency – Life with Disease Alagille syndrome – Diagnostics Factor VIII deficiency – Treatment Splenic marginal zone lymphoma – Basic Information Undifferentiated sarcoma – Life with Disease Synovial sarcoma KBG syndrome – Life with Disease Choroid melanoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bgb-15025 Citrate REGN7544 ALLERGEN EXTRACTS IHMA-2121771-2 Felzartamab Gtaexs617 Ascorbic Acid UDONITRECTAG Cobolimab Vutrisiran Varenicline Ipilimumab Mk-0616 Febuxostat Hemihydrate Folinic Acid Poa Pratensis Pollen Extract Vimseltinib IADADEMSTAT A/H1N1 INFLUENZA VACCINE TETANUS TOXOID More therapies…

    Learn about Your Condition

    Chondropathy Wiskott-Aldrich syndrome Acquired haemophilia Transplantation complication Cystic fibrosis lung Spinal muscular atrophy Round cell liposarcoma Alcoholism Carcinoid tumour pulmonary Ulcerative keratitis Giant cell arteritis Postprandial hypoglycaemia Arteriovenous malformation Fabry's disease Oral neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dermatitis atopic

  • Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Belgium Czechia Denmark Estonia Finland Germany +5

  • Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Rocatinlimab
    Croatia Czechia Germany Greece Hungary Italy +6

  • Study on Etrasimod Arginine for Patients with Ulcerative Colitis, Alopecia Areata, Atopic Dermatitis, and Eosinophilic Esophagitis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Alopecia areata
    • Colitis ulcerative
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium

  • Study on Preventing Atopic Dermatitis in High-Risk Children Using Paraffin White Soft Cream

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Paraffin White Soft
    Germany

  • Study on the Effectiveness and Safety of JNJ-95475939 and Dupilumab for Treating Moderate to Severe Atopic Dermatitis in Adults

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dupilumab
    Germany Poland Spain

  • Study on the Effectiveness and Safety of Lunsekimig (SAR443765) for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • LUNSEKIMIG
    Czechia Poland
Previous Page
1 … 5 6 7 8 9 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!